Global Colorectal Cancer Diagnostics & Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026


Mar, 2021 | Report ID: 170679 | 156 | Pharmaceuticals and Healthcare

The Colorectal Cancer Diagnostics & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Colorectal Cancer Diagnostics & Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Colorectal Cancer Diagnostics & Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Colorectal Cancer Diagnostics & Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Colorectal Cancer Diagnostics

Colorectal Cancer Therapeutics

Market segment by Application, can be divided into

Hospitals

Specialty Clinics

Others

Market segment by players, this report covers

Biocept

Cancer Genetics

Foundation Medicine

Sysmex Corporation

Danaher Corporation

Epigenomics

Illumina

Rosetta Genomics

Exact Science Corporation

Pathway Genomics Corporation

Taiho Pharma

Merck KGaA

Amgen

Takeda

Roche

Eli Lilly

Sanofi

Regeneron

Bayer

Onyx

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Colorectal Cancer Diagnostics & Therapeutics

1.2 Classification of Colorectal Cancer Diagnostics & Therapeutics by Type

1.2.1 Overview: Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type in 2020

1.2.3 Colorectal Cancer Diagnostics

1.2.4 Colorectal Cancer Therapeutics

1.3 Global Colorectal Cancer Diagnostics & Therapeutics Market by Application

1.3.1 Overview: Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Others

1.4 Global Colorectal Cancer Diagnostics & Therapeutics Market Size & Forecast

1.5 Global Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast by Region

1.5.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Region, (2016-2021)

1.5.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size and Prospect (2016-2026)

1.5.4 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size and Prospect (2016-2026)

1.5.6 South America Colorectal Cancer Diagnostics & Therapeutics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Colorectal Cancer Diagnostics & Therapeutics Market Drivers

1.6.2 Colorectal Cancer Diagnostics & Therapeutics Market Restraints

1.6.3 Colorectal Cancer Diagnostics & Therapeutics Trends Analysis

2 Company Profiles

2.1 Biocept

2.1.1 Biocept Details

2.1.2 Biocept Major Business

2.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.1.4 Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Biocept Recent Developments and Future Plans

2.2 Cancer Genetics

2.2.1 Cancer Genetics Details

2.2.2 Cancer Genetics Major Business

2.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.2.4 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Cancer Genetics Recent Developments and Future Plans

2.3 Foundation Medicine

2.3.1 Foundation Medicine Details

2.3.2 Foundation Medicine Major Business

2.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.3.4 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Foundation Medicine Recent Developments and Future Plans

2.4 Sysmex Corporation

2.4.1 Sysmex Corporation Details

2.4.2 Sysmex Corporation Major Business

2.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.4.4 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Sysmex Corporation Recent Developments and Future Plans

2.5 Danaher Corporation

2.5.1 Danaher Corporation Details

2.5.2 Danaher Corporation Major Business

2.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.5.4 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Danaher Corporation Recent Developments and Future Plans

2.6 Epigenomics

2.6.1 Epigenomics Details

2.6.2 Epigenomics Major Business

2.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.6.4 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Epigenomics Recent Developments and Future Plans

2.7 Illumina

2.7.1 Illumina Details

2.7.2 Illumina Major Business

2.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.7.4 Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Illumina Recent Developments and Future Plans

2.8 Rosetta Genomics

2.8.1 Rosetta Genomics Details

2.8.2 Rosetta Genomics Major Business

2.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.8.4 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Rosetta Genomics Recent Developments and Future Plans

2.9 Exact Science Corporation

2.9.1 Exact Science Corporation Details

2.9.2 Exact Science Corporation Major Business

2.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.9.4 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Exact Science Corporation Recent Developments and Future Plans

2.10 Pathway Genomics Corporation

2.10.1 Pathway Genomics Corporation Details

2.10.2 Pathway Genomics Corporation Major Business

2.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.10.4 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Pathway Genomics Corporation Recent Developments and Future Plans

2.11 Taiho Pharma

2.11.1 Taiho Pharma Details

2.11.2 Taiho Pharma Major Business

2.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.11.4 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Taiho Pharma Recent Developments and Future Plans

2.12 Merck KGaA

2.12.1 Merck KGaA Details

2.12.2 Merck KGaA Major Business

2.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.12.4 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Merck KGaA Recent Developments and Future Plans

2.13 Amgen

2.13.1 Amgen Details

2.13.2 Amgen Major Business

2.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.13.4 Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Amgen Recent Developments and Future Plans

2.14 Takeda

2.14.1 Takeda Details

2.14.2 Takeda Major Business

2.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.14.4 Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Takeda Recent Developments and Future Plans

2.15 Roche

2.15.1 Roche Details

2.15.2 Roche Major Business

2.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.15.4 Roche Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Roche Recent Developments and Future Plans

2.16 Eli Lilly

2.16.1 Eli Lilly Details

2.16.2 Eli Lilly Major Business

2.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.16.4 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Eli Lilly Recent Developments and Future Plans

2.17 Sanofi

2.17.1 Sanofi Details

2.17.2 Sanofi Major Business

2.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.17.4 Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Sanofi Recent Developments and Future Plans

2.18 Regeneron

2.18.1 Regeneron Details

2.18.2 Regeneron Major Business

2.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.18.4 Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Regeneron Recent Developments and Future Plans

2.19 Bayer

2.19.1 Bayer Details

2.19.2 Bayer Major Business

2.19.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.19.4 Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Bayer Recent Developments and Future Plans

2.20 Onyx

2.20.1 Onyx Details

2.20.2 Onyx Major Business

2.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

2.20.4 Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Onyx Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Colorectal Cancer Diagnostics & Therapeutics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Colorectal Cancer Diagnostics & Therapeutics Players Market Share

3.2.2 Top 10 Colorectal Cancer Diagnostics & Therapeutics Players Market Share

3.2.3 Market Competition Trend

3.3 Colorectal Cancer Diagnostics & Therapeutics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Colorectal Cancer Diagnostics & Therapeutics Revenue and Market Share by Type (2016-2021)

4.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Application (2016-2021)

5.2 Colorectal Cancer Diagnostics & Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2026)

6.2 North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2026)

6.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country

6.3.1 North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2016-2026)

6.3.2 United States Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

6.3.3 Canada Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

6.3.4 Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2026)

7.2 Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2026)

7.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country

7.3.1 Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2016-2026)

7.3.2 Germany Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

7.3.3 France Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

7.3.5 Russia Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

7.3.6 Italy Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2026)

8.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2026)

8.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region

8.3.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Region (2016-2026)

8.3.2 China Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

8.3.3 Japan Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

8.3.4 South Korea Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

8.3.5 India Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

8.3.7 Australia Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2026)

9.2 South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2026)

9.3 South America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country

9.3.1 South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2016-2026)

9.3.2 Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

9.3.3 Argentina Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2026)

10.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2026)

10.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country

10.3.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2016-2026)

10.3.2 Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

10.3.4 UAE Colorectal Cancer Diagnostics & Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Colorectal Cancer Diagnostics & Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Region (2021-2026)

Table 6. Biocept Corporate Information, Head Office, and Major Competitors

Table 7. Biocept Major Business

Table 8. Biocept Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 9. Biocept Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Cancer Genetics Corporate Information, Head Office, and Major Competitors

Table 11. Cancer Genetics Major Business

Table 12. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 13. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Foundation Medicine Corporate Information, Head Office, and Major Competitors

Table 15. Foundation Medicine Major Business

Table 16. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 17. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Sysmex Corporation Corporate Information, Head Office, and Major Competitors

Table 19. Sysmex Corporation Major Business

Table 20. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 21. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Danaher Corporation Corporate Information, Head Office, and Major Competitors

Table 23. Danaher Corporation Major Business

Table 24. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 25. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Epigenomics Corporate Information, Head Office, and Major Competitors

Table 27. Epigenomics Major Business

Table 28. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 29. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Illumina Corporate Information, Head Office, and Major Competitors

Table 31. Illumina Major Business

Table 32. Illumina Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 33. Illumina Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Rosetta Genomics Corporate Information, Head Office, and Major Competitors

Table 35. Rosetta Genomics Major Business

Table 36. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 37. Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Exact Science Corporation Corporate Information, Head Office, and Major Competitors

Table 39. Exact Science Corporation Major Business

Table 40. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 41. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Pathway Genomics Corporation Corporate Information, Head Office, and Major Competitors

Table 43. Pathway Genomics Corporation Major Business

Table 44. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 45. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Taiho Pharma Corporate Information, Head Office, and Major Competitors

Table 47. Taiho Pharma Major Business

Table 48. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 49. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 51. Merck KGaA Major Business

Table 52. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 53. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Amgen Corporate Information, Head Office, and Major Competitors

Table 55. Amgen Major Business

Table 56. Amgen Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 57. Amgen Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Takeda Corporate Information, Head Office, and Major Competitors

Table 59. Takeda Major Business

Table 60. Takeda Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 61. Takeda Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Roche Corporate Information, Head Office, and Major Competitors

Table 63. Roche Major Business

Table 64. Roche Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 65. Roche Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 67. Eli Lilly Major Business

Table 68. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 69. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Sanofi Corporate Information, Head Office, and Major Competitors

Table 71. Sanofi Major Business

Table 72. Sanofi Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 73. Sanofi Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Regeneron Corporate Information, Head Office, and Major Competitors

Table 75. Regeneron Major Business

Table 76. Regeneron Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 77. Regeneron Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Bayer Corporate Information, Head Office, and Major Competitors

Table 79. Bayer Major Business

Table 80. Bayer Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 81. Bayer Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Onyx Corporate Information, Head Office, and Major Competitors

Table 83. Onyx Major Business

Table 84. Onyx Colorectal Cancer Diagnostics & Therapeutics Product and Solutions

Table 85. Onyx Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million) by Players (2019-2021)

Table 87. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Players (2019-2021)

Table 88. Breakdown of Colorectal Cancer Diagnostics & Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Colorectal Cancer Diagnostics & Therapeutics Players Head Office, Products and Services Provided

Table 90. Colorectal Cancer Diagnostics & Therapeutics Mergers & Acquisitions in the Past Five Years

Table 91. Colorectal Cancer Diagnostics & Therapeutics New Entrants and Expansion Plans

Table 92. Global Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million) by Type (2016-2021)

Table 93. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Type (2016-2021)

Table 94. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Forecast by Type (2021-2026)

Table 95. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2021)

Table 96. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Forecast by Application (2021-2026)

Table 97. North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 98. North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 99. North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 100. North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 101. North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 102. North America Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue by Region (2021-2026) & (USD Million)

Table 115. South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 116. South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 117. South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 118. South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 119. South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 120. South America Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Colorectal Cancer Diagnostics & Therapeutics Picture

Figure 2. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type in 2020

Figure 3. Colorectal Cancer Diagnostics

Figure 4. Colorectal Cancer Therapeutics

Figure 5. Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Application in 2020

Figure 6. Hospitals Picture

Figure 7. Specialty Clinics Picture

Figure 8. Others Picture

Figure 9. Global Colorectal Cancer Diagnostics & Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Colorectal Cancer Diagnostics & Therapeutics Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Region (2016-2026)

Figure 12. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Region in 2020

Figure 13. North America Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Colorectal Cancer Diagnostics & Therapeutics Market Drivers

Figure 19. Colorectal Cancer Diagnostics & Therapeutics Market Restraints

Figure 20. Colorectal Cancer Diagnostics & Therapeutics Market Trends

Figure 21. Biocept Recent Developments and Future Plans

Figure 22. Cancer Genetics Recent Developments and Future Plans

Figure 23. Foundation Medicine Recent Developments and Future Plans

Figure 24. Sysmex Corporation Recent Developments and Future Plans

Figure 25. Danaher Corporation Recent Developments and Future Plans

Figure 26. Epigenomics Recent Developments and Future Plans

Figure 27. Illumina Recent Developments and Future Plans

Figure 28. Rosetta Genomics Recent Developments and Future Plans

Figure 29. Exact Science Corporation Recent Developments and Future Plans

Figure 30. Pathway Genomics Corporation Recent Developments and Future Plans

Figure 31. Taiho Pharma Recent Developments and Future Plans

Figure 32. Merck KGaA Recent Developments and Future Plans

Figure 33. Amgen Recent Developments and Future Plans

Figure 34. Takeda Recent Developments and Future Plans

Figure 35. Roche Recent Developments and Future Plans

Figure 36. Eli Lilly Recent Developments and Future Plans

Figure 37. Sanofi Recent Developments and Future Plans

Figure 38. Regeneron Recent Developments and Future Plans

Figure 39. Bayer Recent Developments and Future Plans

Figure 40. Onyx Recent Developments and Future Plans

Figure 41. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Players in 2020

Figure 42. Colorectal Cancer Diagnostics & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 43. Global Top 3 Players Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share in 2020

Figure 44. Global Top 10 Players Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share in 2020

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 46. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Type in 2020

Figure 47. Global Colorectal Cancer Diagnostics & Therapeutics Market Share Forecast by Type (2021-2026)

Figure 48. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Share by Application in 2020

Figure 49. Global Colorectal Cancer Diagnostics & Therapeutics Market Share Forecast by Application (2021-2026)

Figure 50. North America Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Type (2016-2026)

Figure 51. North America Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Application (2016-2026)

Figure 52. North America Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Country (2016-2026)

Figure 53. United States Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Canada Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Mexico Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Europe Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Type (2016-2026)

Figure 57. Europe Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Application (2016-2026)

Figure 58. Europe Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Country (2016-2026)

Figure 59. Germany Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. France Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. United Kingdom Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Russia Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Italy Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Type (2016-2026)

Figure 65. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Region (2016-2026)

Figure 67. China Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Japan Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South Korea Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. India Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Australia Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South America Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Type (2016-2026)

Figure 74. South America Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Application (2016-2026)

Figure 75. South America Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Country (2016-2026)

Figure 76. Brazil Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Argentina Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Type (2016-2026)

Figure 79. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Sales Market Share by Application (2016-2026)

Figure 80. Middle East and Africa Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Country (2016-2026)

Figure 81. Turkey Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. UAE Colorectal Cancer Diagnostics & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source

Sample Request is not available